Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Conduit Pharmaceuticals Inc. - Common Stock (NQ: CDT )

0.0815 -0.0005 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,697,262
Open 0.0818
Bid (Size) 0.0771 (10)
Ask (Size) 0.0800 (7)
Prev. Close 0.0820
Today's Range 0.0770 - 0.0835
52wk Range 0.0761 - 7.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
From Conduit Pharmaceuticals
Via GlobeNewswire

Performance

YTD
-98.26%
-98.26%
1 Month
-14.39%
-14.39%
3 Month
-39.27%
-39.27%
6 Month
-95.47%
-95.47%
1 Year
-98.86%
-98.86%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?
Via InvestorPlace
What's Going On With Conduit Pharmaceuticals Shares Today?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
From Conduit Pharmaceuticals
Via GlobeNewswire
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
From Conduit Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Conduit Pharmaceuticals
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
From Conduit Pharmaceuticals
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.